Search Results - "de Miranda, Daniel A P"

Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection by Corsini, Camila A, Filgueiras, Priscilla S, Almeida, Nathalie BF, Miranda, Daniel AP de, Gomes, Sarah VC, Lourenço, Adelina Junia, Bicalho, Cecilia MF, Assis, Jessica V de, Amorim, Raquel NH, Silva, Raphael A, Vilela, Raquel VR, Lima, Tulio M, Abreu, Daniel PB de, Alvim, Renata GF, Castilho, Leda R, Martins-Filho, Olindo A, Otta, Dayane A, Grenfell, Rafaella FQ

“…The COVID-19 pandemic has caused a severe global health and economic crisis, with significant consequences for human mortality and morbidity. Therefore, there…”
Get full text

Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil by de Miranda, Daniel A P, Gomes, Sarah V C, Filgueiras, Priscilla S, Corsini, Camila A, Almeida, Nathalie B F, Silva, Raphael A, Medeiros, Maria Izabella V A R C, Vilela, Raquel V R, Fernandes, Gabriel R, Grenfell, Rafaella F Q

“…A growing number of long COVID cases after infection have been reported. By definition, long COVID is the condition whereby affected individuals do not recover…”
Get full text

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study by Grenfell, Rafaella F. Q., Almeida, Nathalie B. F., Filgueiras, Priscilla S., Corsini, Camila A., Gomes, Sarah V. C., de Miranda, Daniel A. P., Lourenço, Adelina J., Martins-Filho, Olindo A., de Oliveira, Jaquelline G., Teixeira-Carvalho, Andrea, Campos, Guilherme R. F., Nogueira, Mauricio L., Alves, Pedro Augusto, Fernandes, Gabriel R., Castilho, Leda R., Lima, Tulio M., de Abreu, Daniel P. B., Alvim, Renata G. F., Silva, Thaís Bárbara de S., Jeremias, Wander de J., Otta, Dayane A., Campi-Azevedo, Ana Carolina

“…BackgroundEffective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic…”
Get full text